FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide - A metabolite of salicylamide

Acta Pharmaceutica

Volumn 54, Issue 3, 2004, Pages 163-176

  Jadrijevic Mladar Takac, Milena ^a   Topič, Dražen Vikič ^b   Govorčinovič, Tihana ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

1D and 2D homo and heteronuclear 1H and 13C NMR; Biotransformation; FT IR; Gentisamide; NSAID; Salicylamide

Indexed keywords

CYTOCHROME P450; DRUG METABOLITE; GENTISAMIDE; GLUCURONOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLAMIDE; SULFOTRANSFERASE;

ANALYTIC METHOD; ARTICLE; BIOTRANSFORMATION; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG METABOLISM; DRUG STRUCTURE; FOURIER TRANSFORMATION; HUMAN; INFRARED SPECTROPHOTOMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; URINALYSIS;

EID: 6344285221     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. nd ed., Harwood Academic Publishers, Amsterdam 1996, p.p. 35-59.
2. N. P. E. Vermuelen, Role of metabolism in chemical toxicity, in Cytochromes P450: Metabolic and Toxicological Aspects (C. Ioanides, Ed.), CRC Press, Boca Raton 1996, p.p. 29-53.
3. U. Holzgrabe, I. Wawer and B. W. K. Diehl, NMR Spectroscopy in Drug Development and Analysis, Wiley-VCH Verlag GmbH, Weinheim 1999.
4. M. Waksmundzka-Hajnos, Chromatographic separations of aromatic carboxylic acids, J. Chromatogr. B 717 (1998) 93-118.
5. th ed., McGraw Hill, New York 2001.
6. X. Xu, H. Hirayama and K. S. Pang, First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation, Drug Metab. Dispos. 17 (1989) 556-563.
7. H. Hirayama and K. S. Pang, First-pass metabolism of gentisamide: influence of intestinal metabolism formation of conjugates. Studies in the once-through vascularly perfused intestine-liver preparation, Drug Metab. Dispos. 18 (1990) 580-587.
8. X. Xu, K. Bing, K. Tang and K. S. Pang, Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugate in single-pass in situ perfused rat liver, J. Pharmacol. Exp. Ther. 253 (1990) 965-973.
9. H. G. Bray, B. E. Rayman and W. V. Thorpe, The fate of certain organic acids and amides in the rabbit, Biochemistry 43 (1948) 561-567.
10. M. Koike, K. Sugeno and M. Hirata, Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes, J. Pharm. Sci. 70 (1981) 308-311.
11. R. G. Tirona and K. S. Pang, Sequestered endoplasmatic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation, Drug Metab. Dispos. 24 (1996) 821-833.
12. M. E. Morris, V. Yuen and K. S. Pang, Competing pathways in drug metabolism. I. An identical, anterior enzymatic distribution for 2- and 5-sulfoconjugation and a posterior localization for glucuronidation of gentisamide in the rat liver, J. Pharmacokinet. Biopharm. 16 (1988) 633-656.
13. S. A. El-Shahawy, Spectroscopic structural studies of salicylic acid, salicylamide and aspirin, Spectrochim. Acta 44A (1988) 903-907.
14. M. C. Etter, Z. Urbanczyk-Lipkovska, T. M. Ameli and T. W. Panunto, Intra-versus intramolecular hydrogen bonds in salicylamide derivatives, J. Crystallogr. Spectrosc. Res. 18 (1988) 491-508.
15. J. Catalan, F. Toriblo and A. U. Acuna, Intramolecular hydrogen bonding and fluorescence of salicylaldehyde, salicylamide, and o-hydroxyacetophenone in gas and condensed phases, J. Phys. Chem. 86 (1982) 303-306.
16. J. Nakamura, M. Katayama, K. Nishida and H. Sasaki, An assessment of indomethacin-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine, Chem. Pharm. Bull. 40 (1992) 1261-1265.
17. J. Nakamura, M. Katayama, K. Nishida and H. Sasaki, An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine, Chem. Pharm. Bull. 40 (1992) 815-818.
18. S. Zaugg, X. Zhang, J. Sweedler and W. Thormann, Determination of salicylate, gentisic acid and salicyluric acid in human urine by capillary electrophoresis with laser-induced fluorescence detection, J. Chromatogr. B: Biomed. Sci. Appl. 752 (2001) 17-31.
19. S. R. Gautam, V. Chungi, A. Hussain, S. Babhair and D. Papadimitrou, A direct and sensitive method for the determination of salicylamide in microplasma samples by high-perfomance liquid chromatography using fluorescence detection, Anal. Lett. 14 (1981) 577-582.
20. A. G. De Boer, J. M. Gubbens-Stibbe, F. H. De Koning, A. Bosma and D. D. Breimer, Assay of underivatized salicylamide in plasma, saliva and urine, J. Chromatogr. 162 (1979) 457-460.
21. J. Vion-Dury, F. Nicoli, G. Torri, M. Kriat, M. Sciaky, A. Davin, P. Viout, S. Confort-Gouny and P. J. Cozzone, High resolution NMR spectroscopy of physiological fluids: from metabolism to physiology, Biochimie 74 (1992) 801-807.
22. 1H NMR spectroscopy of normal and pathological human plasma: complete water suppression and further assignment of resonances, Biochimie 74 (1992) 913-918.
23. M. Kriat, S. Confort-Gouny, J. Vion-Dury, M. Sciaky, P. Viout and P. J. Cozzone, Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards, NMR Biomed. 5 (1992) 179-184.
24. M. Kriat, J. Vion-Dury, S. Confort-Gouny, R. Fevre, P. Viout, M. Sciaky, H. Sari and P. J. Cozzone, Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumours, J. Lipid Res. 34 (1993) 1009-1019.
25. C. L. Perrin, E. R. Johnston, C. P. Lollo and P. A. Kobrin, NMR studies of base-catalysed proton exchange in amides, J. Amer. Chem. Soc. 103 (1981) 4691-4696.
26. T. L. Brown, L. G. Butler, D. Y. Curtin, Y. Hiyama, I. C. Paul and R. B. Wilson, Deuterium nuclear quadrupole resonance spectra of non-linear hydrogen bonds, J. Amer. Chem. Soc. 104 (1982) 1172-1177.
27. th ed., John Wiley, New York 1991.
28. 13C-NMR- Spektroskopie, John Wiley, Chichester 1991.